67 results
Summary of dosing recommendations in renal impairment of commonly used hypoglycaemic agents

#Diabetes #Diabetic #Medications #Pharmacology #Dosing
Summary of dosing ... recommendations in renal ... #Dosing #Renal ... #Impairment #CKD ... #Table #GFR #Hypoglycemics
Adjusted Pain Medication Dosing based on GFR

#Renal #Dosing #Pain #Pharmacology #Opiates #CKD #Gabapentin #Table
Pain Medication Dosing ... based on GFR ... #Renal #Dosing # ... Pharmacology #Opiates #CKD ... #Gabapentin #Table
Definitions of AKI, CKD, AKD
Acute Kidney Injury (AKI):
 • Increase in SCr by 2 50% within
Kidney Disease (CKD ... ): • GFR < 60 ... • AKI, OR • GFR ... ): • GFR ≥ 60 ... per 1.73 m2 • Stable
The GFR Clock for Staging CKD

Staging CKD is most frequently done by calculating the estimated glomerular
Staging CKD Staging ... CKD is most frequently ... , CKD can be staged ... Using the GFR clock ... cut-offs for each CKD
Interpreting Kidney Biomarkers

↑ Creatinine: 
 • AKI, CKD
 • Medications that lead to nephroprotective ↓ in
Creatinine: • AKI, CKD ... nephroprotective ↓ in GFR ... Medications that ↓ renal ... Cystatin C: • AKI, CKD ... Biomarkers #Kidney #renal
Reduced DOAC Dosing for Atrial Fibrillation 

#DOAC #Reduced #Dosing #Reduction #Dose #Anticoagulation #Pharmacology #AFib #Renal #CKD
Reduced DOAC Dosing ... DOAC #Reduced #Dosing ... Pharmacology #AFib #Renal ... #CKD #AtrialFibrillation
Renal Failure Prognosis - The eGFR and proteinuria offers a general prognosis as demonstrated in the
Renal Failure Prognosis ... - The eGFR and ... #CKD #EGFR #Proteinuria
Effects of Prostaglandins and NSAIDs on the Kidney
Effects of Prostaglandins on the Kidney:
 • The vasodilatory
importance in renal ... production of renal ... is increased in CKD ... prolonged NSAID use in CKD ... with GFR > 30 and
DOAC Cheat Sheet
 • Apixaban, Dabigatran, Edoxaban, Rivaroxaban
 • Renal Dosing
 • Common Drug interactions
 •
Rivaroxaban • Renal ... Dosing • Common ... anticoagulation #CheatSheet #dosing ... #ckd #pharmacology
Selected Clinical Trials of SGLT2 inhibitors in CVD and CKD
EMPA-REG OUTCOME - Empagliflozin lowered CV events
and CKD EMPA-REG ... SGLT2i in HF and CKD ... + T2DM; first renal ... visualabstract #table ... #CVD #CKD